HIGHBRIDGE CAPITAL MANAGEMENT LLC
Q2 2022 Form 13-F

NEW YORK, NEW YORK
CIK 0000919185 · CRD 134776 · SEC-registered investment adviser
$4.4B Reported Value Total

HIGHBRIDGE CAPITAL MANAGEMENT, LLC reports 24 total accounts under management (AUM). There are 24 discretionary accounts valued at $7,919,028,894, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
116 funds · $43.2B gross asset value
Hedge Fund: $26.5B · Private Equity Fund: $12.6B · Other: $2.1B · Securitized Asset Fund: $1.6B · Real Estate Fund: $451.3M
Source: Form ADV filed 2026-03-31
Reported value
$4.4B
Quarter over quarter
-7.1%
Holdings
291
Top-10 concentration
17.2%

Filing Structure

Reports holdings for

  • GAVEA INVESTIMENTOS LTDA (not a 13F filer in our records) · File #028-14525 · Q2 2013 – Q2 2013

Key People

Form ADV owners & control persons
Aditya Bindal
CHIEF RISK OFFICER
Marc David Creatore
CHIEF OPERATING OFFICER/MANAGING DIRECTOR/MEMBER OF THE BOARD OF MANAGERS (HIGHBRIDGE CAPITAL MANAGEMENT, LLC)
Jason Keith Hempel
CO-CHIEF INVESTMENT OFFICER/MANAGING DIRECTOR/MEMBER OF THE BOARD OF MANAGERS (HIGHBRIDGE CAPITAL MANAGEMENT, LLC)
Q1 2022
Q3 2022
Go to latest

Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.

Loading 13F Metrics

Q2 2022 13F filing summary

Period of report June 30, 2022
Filed August 11, 2022
Form 13F-HR
Reported value $4.4B
Positions 291
Change in reported value +2.1%
New positions 104
Exited positions 62
Position turnover 47.0%
Top-10 concentration 17.2%

13F filings by quarter

Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
 299 $4.1B
Q1 2026 13F
Filed May 15, 2026
 239 $3.1B
Q4 2025 13F
Filed Feb 11, 2026
 165 $3.1B
Q3 2025 13F
Filed Nov 10, 2025
 136 $2.3B
Q2 2025 13F
Filed Aug 12, 2025
 128 $2.5B
Q1 2025 13F
Filed May 12, 2025
 104 $2.5B
Q4 2024 13F
Filed Feb 12, 2025
 128 $2.7B
Q3 2024 13F
Filed Nov 8, 2024
 109 $3.1B
Q2 2024 13F
Filed Aug 12, 2024
 103 $3.1B
Q1 2024 13F
Filed May 10, 2024
 91 $2.7B
Q4 2023 13F
Filed Feb 12, 2024
 84 $2.5B
Q3 2023 13F
Filed Nov 13, 2023
 115 $2.4B
Q2 2023 13F
Filed Aug 11, 2023
 105 $2.3B
Q1 2023 13F
Filed May 11, 2023
 126 $2.7B
Q4 2022 13F
Filed Feb 13, 2023
 190 $3.6B
Q3 2022 13F
Filed Nov 14, 2022
 322 $7.1B
Q2 2022 13F
Filed Aug 11, 2022
 291 $4.4B
Q1 2022 13F
Filed May 11, 2022
 280 $4.3B
Q4 2021 13F
Filed Feb 11, 2022
 256 $4.6B
Q3 2021 13F
Filed Nov 12, 2021
 132 $3.8B

33 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2022

# Holding Reported value % of portfolio
1 SPY P SPDR S&P 500 ETF TR $264.1M 6.02%
2 PSTH PERSHING SQUARE TONTINE HLDG $90.8M 2.07%
3 DISH 0 12/15/25 DISH NETWORK CORPORATION $58.5M 1.33%
4 TWTR 0.25 06/15/24 TWITTER INC $56.9M 1.3%
5 DHR DANAHER CORPORATION $55.7M 1.27%
6 GFLU GFL ENVIRONMENTAL INC $52.3M 1.19%
7 AMYT AMRYT PHARMA PLC $44.3M 1.01%
8 IART 0.5 08/15/25 INTEGRA LIFESCIENCES HLDGS C $43.8M 1.0%
9 COLL 2.625 02/15/26 COLLEGIUM PHARMACEUTICAL INC $43.2M 0.98%
10 LITE 0.25 03/15/24 LUMENTUM HLDGS INC $43.2M 0.98%
11 ACCD 0.5 04/01/26 ACCOLADE INC $42.8M 0.97%
12 LCII 1.125 05/15/26 LCI INDS $37.6M 0.86%
13 ENV 1.75 06/01/23 ENVESTNET INC $36.9M 0.84%
14 IPOF SOCIAL CAPITAL HEDOSOPHA HLD $34.8M 0.79%
15 RCL 4.25 06/15/23 ROYAL CARIBBEAN GROUP $34.6M 0.79%
16 PATK PATRICK INDS INC $34.5M 0.79%
17 ACOR 6 12/01/24 ACORDA THERAPEUTICS INC $34.4M 0.78%
18 PRTK 4.75 05/01/24 PARATEK PHARMACEUTICALS INC $33.4M 0.76%
19 TBPH 3.25 11/01/23 THERAVANCE BIOPHARMA INC $33.1M 0.75%
20 OSIS 1.25 09/01/22 OSI SYSTEMS INC $31.2M 0.71%

Values as reported on the Q2 2022 Form 13F. Every position is in the holdings table below.

Loading Activities
Loading Sector Allocation
Crunching numbers
Loading Performance
Finding Potential New Buys
Building table
Loading SEC filing data
Loading Form 4 Filings
Loading 13D/G filings